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This work is devoted to the study of the immunoreactivity of histone Hl” and its major structural domains in mononu- 
cleosomes. Three types of antibody populations were used: (i) anti-Hl” which reacted with antigenic determinants 
situated along the whole polypeptide chain; (ii) anti-GHS which recognized epitopes located in the globular region; and 
(iii) anti-C-tail antibodies reacting specifically with fragment 99193 of the protein molecule. The anti-GHS antibodies 
gave a weak reaction, the C-tail-specific antibodies reacted relatively strongly and the antiserum to the intact molecule 
showed an intermediate l vel of reactivity. The relative intensities of the immunoreaction could be interpreted as reflecting 
the exposure of the antigenic determinants of the individual protein domains in the monosome particle. 
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1. INTRODUCTION 
All lysine-rich histones studied thus far possess a 
characteristic three-domain structure consisting of 
a short basic random-coiled N-terminal region 
(‘nose’), an apolar globular central region (‘head’) 
and a flexible highly basic C-terminal half [l-4]. 
The globular part of Hl occupies a position close 
to the entry and exit points of the DNA in the 
nucleosome [5,6], while the C-terminus extends 
over the linker DNA [7]. It is the C-tail of the 
molecules that is responsible for the folding of the 
fibre into higher-order structures. 
Histone Hl and its differentiation-specific 
counterparts (histones H5 and Hl”) perform 
distinct functions in the cell. Hl is present in all cell 
types, irrespective of their proliferation and dif- 
ferentiation status. The accumulation of the 
erythrocyte-specific histone H5 is connected to the 
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irreversible inactivation of the genome during the 
final stages of maturation of the red blood cell 
[8,9]. Hl” is characteristically present in tissues 
with little cell division both in vertebrates and in- 
vertebrates [lo-171. This protein species is also in- 
volved in terminal differentiation [ 18,191 but its ac- 
tion can be easily reversed under conditions inap- 
propriate for the execution of the differentiated 
function [20]. The functional differences among 
the distinct subtypes of histone Hl suggest that the 
interaction of the respective homologous domains 
with chromatin might be different. 
In an attempt to approach the issue of how the 
different structural domains of histone Hl” are 
situated in monosomes we studied the interaction 
of antibodies to defined regions of the protein 
molecule with the monosome-contained antigen. 
The antibody binding was assayed by solid-phase 
ELISA. 
2. MATERIALS AND METHODS 
2.1. Isolation of nuclei and mononucleosomes 
Mouse liver nuclei were obtained by detergent treatment [15]. 
Chromatin, highly enriched with monosomes, was isolated 
essentially as in 1211: the autodigestion being performed in 5 
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mM Tris-HCI, pH 8.0, 0.25 M sucrose, 5 mM MgCl2, 1 mM 
CaC12, 1 mM PMSF, and the dialysis in 5 mM Tris-HCl, pH 8.0, 
0.5 mM EDTA. Alternatively, monosomes were purified by 
sucrose density centrifugation of chromatin released from 
nuclei by mild micrococcal nuclease treatment. 
2.2. Purification of histone HI ’ and .,s individual domains 
Hl” was isolated from mouse li- r by 5% HCl04 and gel 
filtration [15]. Its purity was checked by electrophoresis n 20% 
polyacrylamide gels in the presence of 0.1% SDS [22]. The cen- 
tral globular domain was obtained by trypsin treatment [23]. 
Pure C-terminal tail containing no part of the globular region 
(amino acids 99-193) was obtained by acetic acid hydrolysis 
followed by SDS-electrophoresis [23]. 
2.3. Immunochemical procedures 
Antibodies were elicited in rabbits against purified Hl” [24]. 
Anti-GH5 was kindly provided by Russanova et al. [25]. Anti- 
C-tail antibodies were obtained out of the total anti-Hl” an- 
tiserum by adsorbance to nitrocellulose filters containing the C- 
fragment and elution of the bound antibodies [26,27]. ELISA 
and immunoblotting were performed as in [28]. 
2.4. DNA electrophoresis 
The DNA content of the monosome preparations was analys- 
ed by electrophoresis n 1.2% agarose gels after standard phenol 
extraction of the DNA. 
3. RESULTS AND DISCUSSION 
3.1. Specificity of the various antibody popula- 
tions used 
The polyclonal antiserum obtained against 
purified intact H lo is specific to this protein [24,29] 
and recognizes epitopes along the whole polypep- 
tide chain (with the possible exception of the short 
N-nose) (Banchev et al., submitted). 
The anti-GHS antibody reacted with those 
fragments of HS which contained the globular 
region or a part of it [25]. On the basis of the ex- 
isting homology between the structured domains of 
H lo and HS [30] it was expected that this antibody 
population would react preferentially with the 
globular region of H lo, which turned out to be the 
case (not shown). 
The anti-C-tail antibodies were thoroughly 
characterized in [27]: they reacted mainly with the 
fragment used for adsorption and showed only 
background reaction with peptides derived from 
other parts of the molecule. 
3.2. Accessibility of HI a and its structural do- 
mains in mononucleosomes 
The availability of Hl’ antigenic determinants 
246 
to antibody binding in monosomes immobilized to 
microtitre wells is an important prerequisite to the 
further studies of the localization of the individual 
protein domains in chromatin particles by ELISA. 
Monosomes were prepared following micrococcal 
nuclease treatment of isolated nuclei (fig. 1). Alter- 
natively, chromatin preparations highly enriched 
with monosomes were obtained following en- 
dogenous nucleolysis and dialysis against low 
ionic-strength buffer (fig. 1). The monosome 
preparations obtained by either method contained 
some of the Hl” antigenic determinants in a form 
accessible to antibodies (fig.2). 
Fig. 1. Agarose gel electrophoretic analysis of the DNA content 
of: (a) chromatin preparations highly enriched with mono- 
somes; (b) monosomes obtained following micrococcal nuclease 
digestion of isolated nuclei and sucrose density gradient cen- 
trifugation; (c) molecular mass marker: AluI-digested pBR322. 
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Fig.2. Comparison of the reactivity of the pure antigen to that 
of the antigen in monosomes by ELISA. The intensity of the 
reaction with Hl” loaded at lOpg/ml was taken as 100%. (0) 
Purified mouse liver Hl” and (0) monosomes reacted with 
anti-Hl” antiserum, (u) purified mouse liver Hl’ and ( q ) 
monosomes reacted with nonimmune serum. 
The immunoreactivity of monosomes with 
domain-specific antibody populations was studied 
as a function of the ionic strength following the 
procedure of Russanova et al. [25]. Monosomes 
were incubated in solutions of different NaCl con- 
centrations, the induced conformational changes, 
if any, were fixed with glutaraldehyde and the 
material was used as an antigen in ELISA perform- 
ed under standard ionic conditions. 
The data in fig.3 show the following things: (i) as 
expected the immunoreactivity was independent of 
the ionic strength (the ion concentration in the 
studied range does not significantly affect the con- 
formation of the monosomes [i.e. 31,321; (ii) the 
anti-GHS antibodies gave a relatively weak reac- 
tion which was nevertheless reproducibly higher 
than that of the nonimmune serum. Literature data 
concerning monosomes are lacking but studies with 
chromatin have yielded controversial results. 
Russanova et al. [25] found that the globular do- 
main was inaccessible to antibodies at all salt con- 
centrations studied while Mendelson et al. [33] ob- 
tained an intense immunoreaction even in 80 mM 
NaCl. Our results seem to be closer to those of 
Russanova et al. [25] as even in monosomes the 
globular domain seems to be relatively inaccessible. 
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Fig.3. Immunoreactivity of monosomes as a function of the 
ionic strength with antibodies to intact Hl” (o), to the trypsin- 
resistant core (*), to the C-tail (v); nonimmune serum (m). The 
intensity of the reaction with pure HI” at the lowest anti-Hl” 
antiserum dilution is taken as 100%. 
The C-tail-specific antibodies reacted relatively 
strongly and the antiserum to the intact molecule 
showed an intermediate level of reactivity, some- 
what closer to the reaction with the anti-GHS. It 
should be noted that the dilutions of the respective 
antibodies were carefully chosen so as to give com- 
parable response with the intact Hl” molecule. In 
such a case, the relative intensities of the im- 
munoreaction could be interpreted as reflecting the 
relative exposure of the antigenic determinants of 
the individual protein domains in the monosome 
particle. 
4. CONCLUDING REMARKS 
The results of this study show that the antigenic 
determinants of the globular part of histone H lo 
are somehow hindered from interaction with an- 
tibodies, most probably due to participation in 
binding to other components of the monosomes 
(DNA or proteins). The C-terminal tail seems to be 
much more accessible to antibodies, meaning that 
it is relatively exposed in the particles. 
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